GPT and pulmonary arterial hypertension: The AST and ALT levels of patients at the time of study inclusion exceeded the normal values in 2% of cases (n = 1, CTEPH), at six months in 8.16% (n = 4, PAH = 2, CTEPH = 2), and at twelve months in 6.12% (n = 3, PAH).